MSTX


Stock Update (NYSE:MSTX): Mast Therapeutics Inc and Savara Announce Approval to List Common Stock on the Nasdaq Capital Market

Mast Therapeutics Inc (NYSEMKT:MSTX) and Savara announced that, pending completion of their proposed merger, the combined company’s common stock has been approved for …

Mast Therapeutics Inc (MSTX) Announces 4Q and and Full Year 2016 Financial and Operating Results

Mast Therapeutics Inc (NYSEMKT:MSTX) reported financial results for the fourth quarter and year ended December 31, 2016. “We are pleased with the progress …

A Glimpse into the Mast Therapeutics Inc (MSTX) and Savara Merger

Mast Therapeutics Inc (NYSEMKT:MSTX) and Savara, a privately held pharmaceutical firm aimed at treating rare respiratory diseases captivated the attention of investors in …

Canaccord Cheers Mast Therapeutics Inc (MSTX) In Light Of Strategic Merger With Savara

Mast Therapeutics Inc (NYSEMKT:MSTX) and privately held pharmaceutical firm Savara Inc. have announced the intent to merge to advance a novel pipeline of …

Company Update (NYSEMKT:MSTX): Mast Therapeutics Inc Announces Initiation of Patient Enrollment in Additional Phase 2 Study of air001 for the Treatment of Heart Failure

Mast Therapeutics Inc (NYSEMKT:MSTX) reported that the first patient has been enrolled in an investigator-sponsored Phase 2 study of the Company’s lead product …

Stock Update (NYSE:MSTX): Mast Therapeutics Inc Announces 3Q:16 Financial Results

Mast Therapeutics Inc (NYSEMKT:MSTX) reported financial results for the quarter ended September 30, 2016. “We are rapidly advancing the clinical development of AIR001 in …

Company Update (NYSE:MSTX): Here’s Why Mast Therapeutics Inc Shares Rose 15% Today

Today, shareholders of Mast Therapeutics Inc (NYSEMKT:MSTX) woke up to a nice 15% pop in the value of their shares, after the drug …

Biotech Stocks: Fad or Trend?

By Dana Lyons A key gauge of biotechnology stocks is testing major trendline support presently – can it hold yet again? When this …

Stock Update (NYSE:MSTX): Here’s Why Mast Therapeutics Inc Shares Are Soaring 16%

Mast Therapeutics Inc (NYSEMKT:MSTX) investors cheer the news that the company’s subsidiary, Aires Pharmaceuticals, has entered into a collaborative agreement with Philips Respironics related to …